HI homepage

Thumbnail
AI reduces readers' kidney lesion interpretation times by over 30%

The tool also can be used on contrasted abdominal scans completed for other clinical indications, helping providers to identify and address suspicious lesions before they worsen.  

Kimberly Powell, vice president, general manager of healthcare at NVIDIA, explains how artificial intelligence (AI) has rapidly expanded in radiology and how many of the companies showing AI products at the Radiological Society of North America (RSNA) 2025 meeting use the company's technology. She said a few key technology launches by GE Healthcare show a deeper integration of NVIDIA's AI technology, and shared what the next generation of "physical AI" will enable autonomous radiology exams.
Nvidia sees major shift in radiology to AI agents and new autonomous imaging systems

“Physical AI agents being able to actually deliver some of these services—all the way into robotic surgery—this is where we're going to see this next chapter of medicine be written,” said Kimberly Powell, vice president and general manager of healthcare at Nvidia.
 

Thumbnail
Judge rejects radiologist’s attempt to revive lawsuit alleging age bias led to her termination

The case dates to July 2019, when breast specialist Claire Hanley, MD, first filed suit against New York City Health and Hospitals Corp. 

money maze payment reimbursement
Anthem defends controversial policy penalizing hospitals who use out-of-network radiologists

Rads and other physicians have roundly criticized the change, labeling the policy as “deeply flawed and operationally unworkable.” 

Lumexa Caitlin Zulla
Lumexa Imaging refinances debts, fills out board of directors

Effective Dec. 10, Brett Brodnax, Bridget Karlin, Matthew Lungren, MD, and Robert Mittl, MD, joined Lumexa’s board of directors. 

ST-RADS scoring system for predicting risk of soft tissue tumor malignancy
Scoring system outperforms standard radiology reports for predicting soft tissue tumor malignancy

The Soft-Tissue Tumor Reporting and Data System (ST-RADS) is an MRI framework that was designed to assess the risk of soft tissue tumors and help providers in managing the finding. 

Around the web

RadNet Chaiman and CEO Howard Berger, MD, explains why the company has invested tens of millions into DeepHealth to rapidly build up a new business model. 

 

Thanks to AI, clinicians can use mammograms to do a lot more than identify signs of breast cancer. Researchers explored data from nearly 50,000 patients, presenting their findings in Heart.

A new analysis is prompting questions regarding how rigorously many of the AI-enabled tools approved by the U.S. Food and Drug Administration are evaluated prior to their clearance.